Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bleyer

Showing results (561-570 of 664) with videos related to

Pageof 67
Sort By:
The Oncologist|October 29, 2017
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate ClearanceLaura B Ramsey, Frank M Balis, Maureen M O'Brien, et al.
Immunity|September 12, 2017
An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and FunctionHyunju Oh, Yenkel Grinberg-Bleyer, Will Liao, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2009
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRDBarry I Freedman, Pamela J Hicks, Meredith A Bostrom, et al.
Research Square|October 3, 2025
An Observational Study of SGLT2 Inhibitors and Their Use in Autosomal Dominant Tubulointerstitial Kidney DiseaseKendrah O Kidd, Adrienne H Williams, Elhussein A E Elhassan, et al.
The Journal of Clinical Investigation|November 25, 2010
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting TregsYenkel Grinberg-Bleyer, David Saadoun, Audrey Baeyens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
EMBO Molecular Medicine|December 9, 2025
Channelrhodopsin variants for high-rate optogenetic neurostimulation at low light intensitiesLennart Roos, Aida Garrido-Charles, Niels Albrecht, et al.
Journal of the American Society of Nephrology : JASN|October 28, 2005
Kidney function as a predictor of noncardiovascular mortalityLinda F Fried, Ronit Katz, Mark J Sarnak, et al.
Rheumatology (Oxford, England)|November 14, 2018
Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in femalesMarie Zikánová, Dawn Wahezi, Arielle Hay, et al.
Pageof 67

Showing results (561-570 of 664) with videos related to

Sort By:
Pageof 67
The Oncologist|October 29, 2017
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate ClearanceLaura B Ramsey, Frank M Balis, Maureen M O'Brien, et al.
Immunity|September 12, 2017
An NF-κB Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and FunctionHyunju Oh, Yenkel Grinberg-Bleyer, Will Liao, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2009
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRDBarry I Freedman, Pamela J Hicks, Meredith A Bostrom, et al.
Research Square|October 3, 2025
An Observational Study of SGLT2 Inhibitors and Their Use in Autosomal Dominant Tubulointerstitial Kidney DiseaseKendrah O Kidd, Adrienne H Williams, Elhussein A E Elhassan, et al.
The Journal of Clinical Investigation|November 25, 2010
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting TregsYenkel Grinberg-Bleyer, David Saadoun, Audrey Baeyens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
EMBO Molecular Medicine|December 9, 2025
Channelrhodopsin variants for high-rate optogenetic neurostimulation at low light intensitiesLennart Roos, Aida Garrido-Charles, Niels Albrecht, et al.
Journal of the American Society of Nephrology : JASN|October 28, 2005
Kidney function as a predictor of noncardiovascular mortalityLinda F Fried, Ronit Katz, Mark J Sarnak, et al.
Rheumatology (Oxford, England)|November 14, 2018
Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in femalesMarie Zikánová, Dawn Wahezi, Arielle Hay, et al.
Pageof 67